| |
| | CDC Moneypox | Updated Interim CDC Guidance for Use of Smallpox Vaccine, Cidofovir, and Vaccinia Immune Globulin (VIG) ... |
 | | This interim guidance updates the June 12, 2003, interim guidance on the use of smallpox vaccine, cidofovir, and vaccinia immune globulin (VIG) for purposes of monkeypox outbreak control in affected states. |
 | | This interim CDC guidance was developed using the best available information about the benefits and risks of smallpox vaccination, VIG, and cidofovir for prevention and management of smallpox, monkeypox and complications of vaccinia infection. |
 | | However, cidofovir has proven anti-monkeypox viral activity in in vitro and in animal studies (12,13). |
| www.cdc.gov /ncidod/monkeypox/treatmentguidelines.htm (3109 words) |
|